Single-Center Experience Using the Cardiohelp System for Neonatal and Pediatric Extracorporeal Membrane Oxygenation

Abstract

OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) systems have continued to evolve and improve with the development of smaller and portable systems. The Cardiohelp (Maquet Getinge Cardiopulmonary AG, Rastatt, Germany) portable life support device is a compact ECMO system used widely in adults and for ECMO transport. Reports of its use in neonatal and pediatric centers remain limited. In this single-center retrospective review, we describe our institutional experience with the Cardiohelp. DESIGN: Single-center retrospective review. SETTING:Neonatal ICUs and PICUs in a tertiary-care children's hospital. PATIENTS:Seventeen pediatric patients on ECMO. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS:Median (interquartile range, IQR) of patient age was 0.5 years (0-7 yr). Eleven of 17 patients were on veno-arterial ECMO, five on veno-venous ECMO, and one on veno-venoarterial ECMO. All veno-venous and veno-venoarterial runs (n = 6) were accomplished with bicaval, dual-lumen cannulae. Median duration on Cardiohelp was 113 hours (IQR 50-140 hr). Median anti-Xa level for patients was 0.43 IU/mL (IQR 0.35-0.47 IU/ mL), with median heparin dose of 23.6 U/kg/hr (IQR 17.6-28.1 U/kg/hr). Median plasma-free hemoglobin was 41.4 mg/dL (IQR 30-60 mg/dL). Circuit change was required in three cases. Fourteen patients survived ECMO, with 13 patients surviving to discharge. CONCLUSIONS:We have used the Cardiohelp system to support 17 neonatal and pediatric ECMO patients, without complications. Further studies are warranted to compare complications, outcomes, and overall cost with other institutions and other existing ECMO systems.

Quantifying potential fluid transfused through pressure monitoring and circuit flushes in pediatric ECMO patients

“…ECMO disposables like Cardiohelp (Getinge, Rastatt, Germany) use internal pressure monitoring that does not require flushing. While this device is intended for the adult population, off-label use in pediatrics has been studied and deemed safe [ 5 ]. Some centers refrain from pressure monitoring entirely in an effort to simplify circuits, thus reducing the chances of line separations, air entrainment, and blood spillage.…”

Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review

“…these patients will need to have their ECMO cannulas and circuits tailored to their size and specific oxygen consumption, which also reduces with age (24). ECMO circuits may vary from 1/4" tubing with a roller pump, through 1/2" tubing with a centrifugal pump to adult integrated pump-oxygenator devices with 3/8" tubing stepped down to 1/4" with a bridge to maintain adequate flow in the oversized oxygenator (25,26). Oxygenators are also sized according to the expected blood flow from 800 cm 2 up to around 7,000 cm 2 .…”

What’s new in neonatal and pediatric extracorporeal membrane oxygenation in 2022–2023? Insights from the EuroELSO congress 2023

“…Currently, many pediatric centers are still using adult centrifugal pumps (3/8 inch) adapted to neonatal circuits (1/4 inch). 22 This circuit adaptation in some centers was associated to several mechanical complications (e.g. increase of oxygenator resistance due to clotting).…”